Literature DB >> 22341531

Body mass trajectories through midlife among adults with class I obesity.

Eric A Finkelstein1, Truls Østbye, Rahul Malhotra.   

Abstract

BACKGROUND: Little is known about the body mass trajectories for adults with class I obesity. Our objective was to map the body mass trajectories through midlife for young adults with class I obesity in the United States.
METHODS: Data from the National Longitudinal Study of Youth 1979 was used to generate a cohort of 1058 men and women, aged 25-33 years with class I obesity in 1990. Group-based trajectory modeling was used to identify the number and shape of the body mass index trajectories from 1990 to 2008 for this cohort.
RESULTS: By 2008, about 15% of men and women with class I obesity in 1990 experienced a body mass index increase to >40 kg/m(2). The trajectory analyses showed that roughly one third of the sample were on 1 of 2 body mass index trajectory groups that culminated with an average BMI well above 35 kg/m(2).
CONCLUSION: The large majority of young adults with class I obesity are likely to gain weight over time. For many, the weight gain will be significant and greatly increase their risk of obesity-related co-morbidities and reduced life expectancy. As a result, bariatric surgery or other intensive weight management options might be warranted.
Copyright © 2013 American Society for Metabolic and Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bariatric; Longitudinal; Obesity; Surgery; Trajectory; United States; Weight

Mesh:

Year:  2012        PMID: 22341531     DOI: 10.1016/j.soard.2012.01.004

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  8 in total

1.  The daily Self-Weighing for Obesity Management in Primary Care Study: Rationale, design and methodology.

Authors:  Gareth R Dutton; Amber W Kinsey; Carrie R Howell; Maria Pisu; Amy E Dobelstein; David B Allison; Pengcheng Xun; David A Levitsky; Kevin Fontaine
Journal:  Contemp Clin Trials       Date:  2021-05-31       Impact factor: 2.261

2.  Body Mass Index Trajectories among Middle-Aged and Elderly Canadians and Associated Health Outcomes.

Authors:  Meng Wang; Yanqing Yi; Barbara Roebothan; Jennifer Colbourne; Victor Maddalena; Peizhong Peter Wang; Guang Sun
Journal:  J Environ Public Health       Date:  2016-01-27

3.  Waist circumference trajectories and risk of type 2 diabetes mellitus in Korean population: the Korean genome and epidemiology study (KoGES).

Authors:  Jooeun Jeon; Keum Ji Jung; Sun Ha Jee
Journal:  BMC Public Health       Date:  2019-06-13       Impact factor: 3.295

4.  Long-term body mass trajectories and hypertension by sex among Chinese adults: a 24-year open cohort study.

Authors:  Ruru Liu; Baibing Mi; Yaling Zhao; Shaonong Dang; Hong Yan
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

5.  Patterns of obesity development before the diagnosis of type 2 diabetes: the Whitehall II cohort study.

Authors:  Dorte Vistisen; Daniel R Witte; Adam G Tabák; Christian Herder; Eric J Brunner; Mika Kivimäki; Kristine Færch
Journal:  PLoS Med       Date:  2014-02-11       Impact factor: 11.069

Review 6.  Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: a systematic review and meta-analysis.

Authors:  G Ribaric; J N Buchwald; T W McGlennon
Journal:  Obes Surg       Date:  2014-03       Impact factor: 4.129

7.  Prevalence of comorbidities and baseline characteristics of LAP-BAND AP® subjects in the Helping Evaluate Reduction in Obesity (HERO) study.

Authors:  Nancy Dreyer; John B Dixon; Ted Okerson; Eric A Finkelstein; Denise Globe
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240

8.  Trajectories of body mass index before the diagnosis of cardiovascular disease: a latent class trajectory analysis.

Authors:  Klodian Dhana; Joost van Rosmalen; Dorte Vistisen; M Arfan Ikram; Albert Hofman; Oscar H Franco; Maryam Kavousi
Journal:  Eur J Epidemiol       Date:  2016-03-08       Impact factor: 8.082

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.